Caraci F, Coluzzi F, Marinangeli F, et al. Modulation of sensitization processes in the management of pain and the importance of descending pathways: a role for tapentadol?. Curr Med Res Opin. 2020;36(6):1015?1024. doi:10.1080/03007995.2020.1748876
Pub Category: MOA
Lu, Kuei Huang S, Lin TY, Wang SJ. Tapentadol Suppresses Glutamatergic Transmission and Neuronal Firing in Rat Hippocampal CA3 Pyramidal Neurons [published online ahead of print, 2019 Dec 11]. Pharmacology. 2019;1?9. doi:10.1159/000504886
Caputi FF, Nicora M, Simeone R, Candeletti S, Romualdi P. Tapentadol: an analgesic that differs from classic opioids due to its noradrenergic mechanism of action. Minerva Med. 2019;110(1):62?78. doi:10.23736/S0026-4806.18.05909-8
Raffa RB, Elling C, Tzschentke TM. Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’. Adv Ther. 2018;35(10):1471?1484. doi:10.1007/s12325-018-0778-x
Zaj?czkowska R, Przew?ocka B, Kocot-K?pska M, Mika J, Leppert W, Wordliczek J. Tapentadol – A representative of a new class of MOR-NRI analgesics. Pharmacol Rep. 2018;70(4):812?820. doi:10.1016/j.pharep.2018.01.005
Bairam AF, Rasool MI, Kurogi K, Liu MC. On the Molecular Basis Underlying the Metabolism of Tapentadol Through Sulfation. Eur J Drug Metab Pharmacokinet. 2017;42(5):793?800. doi:10.1007/s13318-016-0392-8
Greco MC, Navarra P, Tringali G. The analgesic agent tapentadol inhibits calcitonin gene-related peptide release from isolated rat brainstem via a serotonergic mechanism. Life Sci. 2016;145:161-165. doi:10.1016/j.lfs.2015.12.032
Eichenbaum G, Göhler K, Etropolski M, et al. Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency. J Opioid Manag. 2015;11(3):211-227. doi:10.5055/jom.2015.0270
Cowan A, Raffa RB, Tallarida CS, et al. Lack of synergistic interaction between the two mechanisms of action of tapentadol in gastrointestinal transit. Eur J Pain. 2014;18(8):1148-1156. doi:10.1002/j.1532-2149.2014.00461.x
Caputi FF, Carretta D, Tzschentke TM, Candeletti S, Romualdi P. Opioid receptor gene expression in human neuroblastoma SH-SY5Y cells following tapentadol exposure. J Mol Neurosci. 2014;53(4):669-676. doi:10.1007/s12031-014-0235-5